NDT Advance Access originally published online on April 12, 2006
Nephrology Dialysis Transplantation 2006 21(8):2120-2126; doi:10.1093/ndt/gfl133
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Clinical Nephrology
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients
1 Service de Néphrologie-Hémodialyse-Transplantation rénale, Hôpital de la Conception, 2 Centre d'Investigation Clinique, Hôpital Sainte Marguerite and 3 Unité d'Epidémiologie Prévention et Santé Publique, Faculté de Médecine de la Timone, Marseille, France
Correspondence and offprint requests to: Prof. Bertrand Dussol, Service de Néphrologie-Hémodialyse-Transplantation rénale, Hôpital de la Conception, 147 Bd Baille, 13385 Marseille Cedex 5, France. Email: bdussol{at}ap-hm.fr
Background. Contrast nephropathy (CN) is a common cause of renal dysfunction that may be prevented by saline hydration and by drugs such as theophylline or furosemide. Whether oral saline hydration is as efficient as intravenous saline hydration is unknown. The preventive efficacy of theophylline and furosemide for CN remains controversial. The purpose of the current study was to evaluate the efficacy of oral saline hydration and of intravenous saline hydration plus theophylline or furosemide for the prevention of CN.
Methods. We prospectively studied 312 patients with chronic renal failure (serum creatinine 201±81 µmol/l, Cockcroft clearance 37±12 ml/min/1.73 m2), who were undergoing various radiological procedures with a non-ionic, low osmolality contrast agent. Patients were randomly assigned to four arms. In arm A, patients received 1 g/10 kg of body weight/day of sodium chloride per os for 2 days before the procedure. In arm B, patients received 0.9% saline intravenously at a rate of 15 ml/kg for 6 h before the procedure. In arm C, patients received the same saline hydration as in arm B plus 5 mg/kg theophylline per os in one dose 1 h before the procedure. In arm D, patients received the same saline hydration as in arm B plus 3 mg/kg of furosemide intravenously just after the procedure.
Results. Patients were well-matched with no significant differences at baseline in any measured parameters. Acute renal failure, defined as an increase in serum creatinine of 44 µmol/l (0.5 mg/dl), occurred in 27 out of 312 patients (8.7%). There was no significant difference between the rate of renal failure in the different arms of the study: five out of 76 (6.6%) in arm A, four out of 77 (5.2%) in arm B, six out of 80 (7.5%) in arm C and 12 out of 79 (15.2%) in arm D. No patient had fluid overload or a significant increase in blood pressure in the 2 days following the radiological procedure. The independent predictors of CN were diabetes mellitus, high baseline serum creatinine and high systolic blood pressure.
Conclusions. Oral saline hydration was as efficient as intravenous saline hydration for the prevention of CN in patients with stage 3 renal diseases. Furosemide and theophylline were not protective.
Keywords: contrast nephropathy; furosemide; randomized trial; renal failure; saline hydration; theophylline
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. H. Endre and J. W. Pickering Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI) Nephrol. Dial. Transplant., October 7, 2009; (2009) gfp501v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Baumgarten and J. H. Ellis Contrast-Induced Nephropathy: Contrast Material Not Required? Am. J. Roentgenol., August 1, 2008; 191(2): 383 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kelly, B. Dwamena, P. Cronin, S. J. Bernstein, and R. C. Carlos Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy Ann Intern Med, February 19, 2008; 148(4): 284 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Weisbord and P. M. Palevsky Prevention of Contrast-Induced Nephropathy with Volume Expansion Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Solomon Contrast media nephropathy--how to diagnose and how to prevent? Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1812 - 1815. [Full Text] [PDF]
|
|